Fennec Pharmaceuticals Inc.
USD10.80
-0.23 (-2.04%)
CEO
Jeffrey S. Hackman
IPO Date
2017-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.02
Prev. Close
$11.03
Day Low
$10.72
Day High
$11.21
52W Low
$5.65
52W High
$11.31
Market Cap
$0.31B
Volume
0.14M
| -395.6 |
| 31 Dec 2023 | FY | 94.1% | -75.5% | 138.1% | -59.7% | -2.66 | 3.56 | -18.6 |
| 31 Dec 2022 | FY | 94.4% | -1544.9% | 923.1% | -88.0% | -9.69 | 5.80 | -10.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -110.0% | -77.4% | 0.32 | 13.54 | -6.6 |
| 31 Dec 2020 | FY | 100.0% | -10652.4% | -62.3% | -57.6% | 0.00 | 13.39 | -9.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -110.1% | -92.4% | 0.00 | 6.11 | -9.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -46.4% | -43.1% | 0.00 | 14.02 | -12.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -26.3% | -24.8% | 0.00 | 17.28 | -21.3 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -78.1% | -70.2% | 0.00 | 9.88 | -54.5 |
| -12.5 |
| 30 Sept 2025 | Q3 | 94.7% | -5.1% | 14.2% | -1.3% | -4.03 | 4.69 | -102.3 |
| 30 Jun 2025 | Q2 | 90.0% | -32.7% | 42.2% | -7.0% | -2.59 | 4.85 | -18.2 |
| 31 Mar 2025 | Q1 | 95.7% | -13.3% | 19.8% | -2.5% | -3.29 | 5.13 | -36.0 |
| 31 Dec 2024 | Q4 | 91.6% | -25.0% | 33.8% | -4.4% | -3.29 | 6.38 | -21.9 |
| 30 Sept 2024 | Q3 | 80.5% | -82.2% | 110.9% | -9.7% | -6.21 | 7.80 | -6.0 |
| 30 Jun 2024 | Q2 | 91.6% | -76.5% | 409.2% | -8.8% | -23.42 | 8.02 | -7.7 |
| 31 Mar 2024 | Q1 | 97.8% | 50.6% | 425.9% | 18.6% | 10.41 | 6.93 | 5.7 |
| 31 Dec 2023 | Q4 | 93.0% | -27.6% | 23.1% | -10.0% | -2.66 | 3.56 | -28.1 |